DCM
ORGO icon

Dupont Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Dupont Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,819
Closed -$69.5K – 1076
2022
Q4 		$69.5K Sell
25,819
-2,767
-10% -$8.07K ﹤0.01% 1021
2022
Q3 		$93K Buy
28,586
+8,146
+40% +$36.8K 0.01% 1065
2022
Q2 		$100K Hold
20,440
– – ﹤0.01% 1178
2022
Q1 		$156K Sell
20,440
-1,808
-8% -$14K 0.01% 1156
2021
Q4 		$206K Buy
22,248
+4,760
+27% +$50.6K 0.01% 1102
2021
Q3 		$249K Sell
17,488
-2,473
-12% -$38.4K 0.01% 1140
2021
Q2 		$332K Buy
+19,961
New +$372K 0.01% 1166

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Dupont Capital Management's ORGO Position: Q1 2023 in Review

Dupont Capital Management sold out of Organogenesis Holdings (ORGO) in Q1 2023, closing a stake of 25,819 shares — an estimated $69.5K sold.

Dupont Capital Management first reported a position in ORGO in Q2 2021 and held it in 7 quarters. The position peaked at $332K in Q2 2021. 131 funds tracked by Wall St. Rank hold ORGO as of Q1 2023.

  • Dupont Capital Management reported no remaining Organogenesis Holdings position as of Q1 2023 after selling out during the quarter.
  • Dupont Capital Management sold 25,819 Organogenesis Holdings shares in Q1 2023, an estimated $69.5K.
  • Dupont Capital Management first reported a position in Organogenesis Holdings in Q2 2021 and held it in 7 quarters.
  • Dupont Capital Management's Organogenesis Holdings position peaked at $332K in Q2 2021.
  • 131 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2023.

Based on Dupont Capital Management's 13F filing for Q1 2023, filed 28 Apr 2023.